Identification and validation of biomarkers based on cellular senescence in mild cognitive impairment

BACKGROUND: Mild cognitive impairment (MCI), a syndrome defined as decline of cognitive function greater than expected for an individual’s age and education level, occurs in up to 22.7% of elderly patients in United States, causing the heavy psychological and economic burdens to families and society...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Songmei, Xia, Tong, Wang, Xinyi, Wang, Haiyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Aging Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176455/
https://www.ncbi.nlm.nih.gov/pubmed/37187578
http://dx.doi.org/10.3389/fnagi.2023.1139789

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176455/
https://www.ncbi.nlm.nih.gov/pubmed/37187578
http://dx.doi.org/10.3389/fnagi.2023.1139789

Ejemplares similares